Biography
Dr. Amer Raheemullah, MD, is Clinical Assistant Professor at Stanford University in the Psychiatry and Behavioral Sciences Department. He specializes in the treatment of addiction, has published chapters and peer-reviewed articles in this area, and is Director of the Addiction Medicine Consult Service at Stanford Hospital. He is board-certified in Addiction Medicine and Internal Medicine and has a special interest in developing novel methods to increase access to addiction treatment, through criminal justice, healthcare, and tech-enabled solutions.
He was born and raised in the Chicagoland area. He started free addiction and education programs in Illinois jails and prisons during his undergraduate degree in Economics at the University of Illinois Urbana-Champaign, which continued through his Internal Medicine residency at the University of Illinois College of Medicine, and eventually started MadinaHouse, a non-profit organization focusing on increasing access to addiction treatment for underserved populations. After completing his Addiction Medicine fellowship at Stanford University School of Medicine, he stayed on the faculty and started the Stanford Hospital Addiction Medicine Consult Service. The service consists of addiction medicine specialists, social workers, substance use navigators, and peer mentors, and by the first year, 30-day readmission rates were reduced by 60% in substance use disorder patients treated by the service, without any increase in length of stay. He also works with the Silicon Valley digital technology startup, Lucid Lane, to put forth a nationwide response to the opioid epidemic, by leveraging data-driven, tech-enabled solutions to scale access to evidence-based treatment.
He was born and raised in the Chicagoland area. He started free addiction and education programs in Illinois jails and prisons during his undergraduate degree in Economics at the University of Illinois Urbana-Champaign, which continued through his Internal Medicine residency at the University of Illinois College of Medicine, and eventually started MadinaHouse, a non-profit organization focusing on increasing access to addiction treatment for underserved populations. After completing his Addiction Medicine fellowship at Stanford University School of Medicine, he stayed on the faculty and started the Stanford Hospital Addiction Medicine Consult Service. The service consists of addiction medicine specialists, social workers, substance use navigators, and peer mentors, and by the first year, 30-day readmission rates were reduced by 60% in substance use disorder patients treated by the service, without any increase in length of stay. He also works with the Silicon Valley digital technology startup, Lucid Lane, to put forth a nationwide response to the opioid epidemic, by leveraging data-driven, tech-enabled solutions to scale access to evidence-based treatment.
View Full Biography »
Professional Summary
Professional Education
- Fellowship: Stanford University Addiction Medicine Fellowship (2018) CA
- Board Certification: American Board of Preventive Medicine, Addiction Medicine (2019)
- Board Certification, Addiction Medicine, American Board of Preventive Medicine (2019)
- Fellowship, Stanford University School of Medicine, Addiction Medicine (2018)
- Board Certification: American Board of Internal Medicine, Internal Medicine (2017)
- Residency, University of Illinois College of Medicine, Internal Medicine (2017)
- Internship, University of Illinois College of Medicine (2014)
Administrative Appointments
- Director, Inpatient Addiction Medicine Consult Service (2018 - Present)
Publications
-
Eccrine Porocarcinoma Presenting as a Hand Cyst.
Raheemullah, A., Allamaneni, S., Weber, S., & Singh, R. (2016). Eccrine Porocarcinoma Presenting as a Hand Cyst. Journal of Hand Surgery, 41(11), e425–e427. -
REPEATED THROMBOSIS AFTER SYNTHETIC CANNABINOID USE
Raheemullah, A., & Laurence, T. N. (2016). REPEATED THROMBOSIS AFTER SYNTHETIC CANNABINOID USE. JOURNAL OF EMERGENCY MEDICINE, 51(5), 540–43. -
Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment.
Raheemullah, A., & Lembke, A. (2019). Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment. JAMA Internal Medicine. -
Cocaine Cessation for Levamisole-Induced Vasculitis: Treating the Underlying Disease.
Raheemullah, A., Melhem, M., & Andruska, N. (2019). Cocaine Cessation for Levamisole-Induced Vasculitis: Treating the Underlying Disease. Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases. -
Exercise and Addiction
Lembke, A., & Raheemullah, A. (2019). Exercise and Addiction. Lifestyle Pscyhiatry (p. 127). American Psychiatric Association Publishing. -
Improving Residency Education on Chronic Pain and Opioid Use Disorder: Evaluation of CDC Guideline-Based Education.
Raheemullah, A., Andruska, N., Saeed, M., & Kumar, P. (2019). Improving Residency Education on Chronic Pain and Opioid Use Disorder: Evaluation of CDC Guideline-Based Education. Substance Use & Misuse, 1–7. -
Fentanyl analogue overdose: Key lessons in management in the synthetic opioid age.
Raheemullah, A., & Andruska, N. (2019). Fentanyl analogue overdose: Key lessons in management in the synthetic opioid age. Journal of Opioid Management, 15(5). -
Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine.
Raheemullah, A., & Lembke, A. (2019). Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine. American Journal of Therapeutics. -
Exercise and Addiction
Lembke, A., & Raheemullah, A. (2019). Exercise and Addiction. LIFESTYLE PSYCHIATRY, 127–39. -
Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine
Raheemullah, A., & Lembke, A. (2021). Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine. AMERICAN JOURNAL OF THERAPEUTICS, 28(4), E504–E508. -
Alcohol and Other Substance Use Disorders
Raheemullah, A., & Benhamou, O.-M. (2022). Alcohol and Other Substance Use Disorders. Concise Guide to Neuropsychiatry and Behavioral Neurology (pp. 337–348). American Psychiatric Publishing, Inc. -
A telehealth inpatient addiction consult service is both feasible and effective in reducing readmission rates.
Deng, H., Raheemullah, A., Fenno, L. E., & Lembke, A. (2022). A telehealth inpatient addiction consult service is both feasible and effective in reducing readmission rates. Journal of Addictive Diseases, 1–8. -
Inpatient Addiction Medicine Consultation on Readmission Rates and Length of Stay
Raheemullah, A., Deng, H., Fenno, L., & Lembke, A. (2022). Inpatient Addiction Medicine Consultation on Readmission Rates and Length of Stay. Journal of Addiction and Prevention, 10(1). -
Inpatient Motivational Interventions for Substance Use Disorder
Raheemullah, A., & Magana, M. (2022). Inpatient Motivational Interventions for Substance Use Disorder. J Mod Nurs Pract Res, 2(4). -
Dopamine Nation: Finding Balance in the Age of Indulgence by Anna Lembke, New York: Dutton, 2021
Raheemullah, A. (2022). Dopamine Nation: Finding Balance in the Age of Indulgence by Anna Lembke, New York: Dutton, 2021. Cambridge Quarterly of Healthcare Ethics, 31(4). -
Peer Review Report For: Creating a standard inpatient opioid withdrawal protocol.
Raheemullah, A. (2022). Peer Review Report For: Creating a standard inpatient opioid withdrawal protocol. . MedEdPublish, 12(7). -
Buprenorphine Microdosing Cross Tapers: A Time for Change
Raheemullah, A., Benhamou, O.-M., Kuo, J., & Lembke, A. (2022). Buprenorphine Microdosing Cross Tapers: A Time for Change. International Journal of Environmental Research and Public Health, 19(24).
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
SHC- Psychiatry Palo Alto, CA
Palo Alto, CAReferring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or e-mail the Referral Center at ReferralCenter@stanfordhealthcare.org

- Send referrals online
- View referral status
- Access medical records